Kyntra Bio, Inc. (KYNB)
6.99
-0.11
(-1.55%)
USD |
NASDAQ |
Sep 18, 16:00
6.99
0.00 (0.00%)
After-Hours: 20:00
Kyntra Bio Market Cap : 28.30M for Sept. 18, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 17, 2026 | 28.75M |
| September 16, 2026 | 30.81M |
| September 15, 2026 | 31.46M |
| September 14, 2026 | 32.51M |
| September 11, 2026 | 32.27M |
| September 10, 2026 | 32.29M |
| September 09, 2026 | 32.55M |
| September 08, 2026 | 33.28M |
| September 04, 2026 | 34.62M |
| September 03, 2026 | 34.38M |
| September 02, 2026 | 34.54M |
| September 01, 2026 | 32.19M |
| August 31, 2026 | 31.50M |
| August 28, 2026 | 32.47M |
| August 27, 2026 | 32.39M |
| August 26, 2026 | 32.82M |
| August 25, 2026 | 32.80M |
| August 24, 2026 | 32.31M |
| August 21, 2026 | 30.45M |
| August 20, 2026 | 29.64M |
| August 19, 2026 | 28.95M |
| August 18, 2026 | 28.38M |
| August 17, 2026 | 27.57M |
| August 14, 2026 | 28.55M |
| August 13, 2026 | 28.51M |
| Date | Value |
|---|---|
| August 12, 2026 | 28.75M |
| August 11, 2026 | 28.63M |
| August 10, 2026 | 28.22M |
| August 07, 2026 | 29.43M |
| August 06, 2026 | 28.26M |
| August 05, 2026 | 28.30M |
| August 04, 2026 | 28.01M |
| August 03, 2026 | 27.37M |
| July 31, 2026 | 27.24M |
| July 30, 2026 | 27.49M |
| July 29, 2026 | 27.45M |
| July 28, 2026 | 28.24M |
| July 27, 2026 | 28.54M |
| July 24, 2026 | 28.46M |
| July 23, 2026 | 28.62M |
| July 22, 2026 | 29.21M |
| July 21, 2026 | 29.55M |
| July 20, 2026 | 28.50M |
| July 17, 2026 | 29.27M |
| July 16, 2026 | 29.92M |
| July 15, 2026 | 29.19M |
| July 14, 2026 | 29.63M |
| July 13, 2026 | 29.73M |
| July 10, 2026 | 30.79M |
| July 09, 2026 | 29.63M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Vericel Corp. | 2.045B |
| Capricor Therapeutics, Inc. | 527.05M |
| ARS Pharmaceuticals, Inc. | 408.69M |
| ACADIA Pharmaceuticals, Inc. | 4.697B |
| Alnylam Pharmaceuticals, Inc. | 32.04B |
Market Cap Related Metrics
| PE Ratio | 0.2164 |
| PS Ratio | 6.126 |
| Price | 6.99 |
| Earnings Yield | 462.2% |
| Normalized PE Ratio | 0.2089 |